Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

856
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
856
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.1K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.1K
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

134.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
134.1K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
Long-term Depression01:05

Long-term Depression

33.7K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commentary on Zacher et al.: How cocaine memories may drive craving and drug instrumentalization.

Addiction (Abingdon, England)·2026
Same author

The role of sphingolipids in major depressive disorder and associated cognitive impairment: interactions with monoaminergic signaling, neuroinflammation, and neurogenesis.

Molecular psychiatry·2026
Same author

Dissociating role of Bassoon in glutamatergic and dopaminergic neurons in alcohol-related behaviour and affective state in mice.

British journal of pharmacology·2026
Same author

Dihydrotestosterone and Finasteride Effects on Alcohol Cue-Elicited Brain Activity in Males With Heavy Episodic Drinking.

Addiction biology·2026
Same author

A network analysis of depression, anxiety, and their associations with kratom (<i>Mitragyna speciosa</i>) use among people who previously used methamphetamine.

Journal of psychoactive drugs·2025
Same author

Kratom (<i>Mitragyna speciosa</i>) as a Replacement for Alcohol Among a Sample of Malaysian Adults with a History of Alcohol Use Problems.

Substance use & misuse·2025
Same journal

A Comprehensive Review of Melatonin as Multi-Pathway Neuroprotectant Against Methamphetamine-Induced Programmed Cell Death: Discovery of the Circadian-Ferroptosis Axis.

Neuro-Signals·2026
Same journal

The Impact of Vitamin D Deficiency on Cognitive and Neuromuscular Functions in Elderly Patients.

Neuro-Signals·2026
Same journal

Tracing the Evolution and Recombination Events of Neurotropic Arenaviridae Viruses: a Bioinformatics Approach.

Neuro-Signals·2025
Same journal

Peripheral Inflammation as a Biomarker of Disease Activity in Relapsing-Remitting MS.

Neuro-Signals·2025
Same journal

Aberrant Hippocampal Neuroregenerative Plasticity in Schizophrenia: Reactive Neuroblastosis as a Possible Pathocellular Mechanism of Hallucination.

Neuro-Signals·2024
Same journal

A Narrative Review - Therapy Options and Therapy Failure in Retinoblastoma.

Neuro-Signals·2022
See all related articles

Related Experiment Video

Updated: Mar 28, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

699

Sphingolipids in Major Depression.

Peter L Jernigan1, Richard S Hoehn, Heike Grassmé

  • 1Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany.

Neuro-Signals
|December 20, 2015
PubMed
Summary
This summary is machine-generated.

The acid sphingomyelinase/ceramide system is crucial in major depression. Its inhibition by antidepressants and ceramide accumulation in the hippocampus contribute to depression-like symptoms and impaired neurogenesis.

More Related Videos

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

8.4K
Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
07:58

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

973

Related Experiment Videos

Last Updated: Mar 28, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

699
Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

8.4K
Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
07:58

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

973

Area of Science:

  • Neuroscience
  • Biochemistry
  • Psychiatry

Background:

  • Major depression pathogenesis is poorly understood, shifting from monoamine deficiency to impaired hippocampal neurogenesis.
  • Reduced neurogenesis in major depression may involve a lack of new neurons, contributing to clinical symptoms.
  • Molecular targets underlying reduced neurogenesis in major depression remain largely unidentified.

Purpose of the Study:

  • To investigate the role of the acid sphingomyelinase/ceramide system in major depression.
  • To identify molecular mechanisms linking antidepressants to neurogenesis.
  • To explore ceramide accumulation as a potential factor in depression-related neurogenesis deficits.

Main Methods:

  • Investigated the effects of acid sphingomyelinase inhibition on antidepressant action.
  • Examined ceramide levels in the hippocampus.
  • Assessed the impact of ceramide accumulation on depression-like behaviors and neurogenesis.

Main Results:

  • Inhibition of the acid sphingomyelinase/ceramide system was found to mediate the effects of tricyclic and tetracyclic antidepressants.
  • Hippocampal ceramide accumulation was correlated with depression-like symptoms.
  • These findings suggest a direct link between the acid sphingomyelinase/ceramide system and neurogenesis in major depression.

Conclusions:

  • The acid sphingomyelinase/ceramide system plays a significant role in the pathogenesis of major depression.
  • Targeting this system may offer novel therapeutic strategies for major depression.
  • Understanding ceramide's role in hippocampal neurogenesis is critical for developing new antidepressant treatments.